Newsenselab GmbH, the Berlin, Germany-based startup behind M-sense, a certified medical app to combat migraines and headaches, raised a six-figure funding round.
Backers included High-Tech Gründerfonds, Think.Health Ventures, Flyinghealth and an additional private business angel.
The company intends to use the funds to further expand M-sense and make it available to a broader group of users.
Led by Markus Dahlem, Chief Medical Officer and Managing Director, Newsenselab provides M-sense, a certified medical app that analyzes the potential trigger factors of migraines and headaches by leveraging Big Data. In the future, it will also offer a personalized prevention and therapy program that is recommended by clinical partners. Sufferers can document their migraine attacks and analyze their triggers.
M-sense is available in the Google Play Store. An iOS version for iPhones is planned for the first quarter of 2017.